JBM (Healthcare) Ltd. Announces Acquisition of Target Group to Enhance Chinese Medicine Portfolio

Reuters
16 Jun
JBM (Healthcare) Ltd. Announces Acquisition of Target Group to Enhance Chinese Medicine Portfolio

JBM (Healthcare) Ltd. announced on June 16, 2025, that its indirect wholly-owned subsidiary has entered into a sale and purchase agreement to acquire the entire issued shares of Kenford Medical Group Company Limited. The acquisition includes Kenford Medical Group and its subsidiaries, which operate a network of over 20 TCM consultancy clinics across Hong Kong. These clinics are strategically positioned in major residential estates and shopping malls, offering convenient access to high-quality traditional Chinese medicine services. The seller, Ever Development Holdings Limited, is a company based in the British Virgin Islands. The acquisition is part of JBM (Healthcare) Ltd.'s strategy to expand its healthcare services portfolio in Hong Kong.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JBM (Healthcare) Ltd. published the original content used to generate this news brief on June 16, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10